Pilot Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Abuse Liability of an Abuse-Deterrent Immediate-Release Formulation (ADAIR)
Clinical trial NCT04232644 · COMPLETED
Trial details
- NCT number
- NCT04232644
- Sponsor
- Vallon Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-27
- Primary completion
- 2019-07-17
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.